These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29934655)

  • 1. A new experience for incorrect insulin administration.
    Kirac CO; Ipekci SH; Kebapcilar L
    Acta Diabetol; 2018 Sep; 55(9):985-986. PubMed ID: 29934655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Taking the peak out of blood pressure. Diabetics can also live spontaneously].
    MMW Fortschr Med; 1999 Dec; 141(49-50):66-7. PubMed ID: 10726151
    [No Abstract]   [Full Text] [Related]  

  • 4. [From human insulin to designer insulin. Why insulin analogs?].
    Jungmann E
    Fortschr Med; 1997 Apr; 115(12):40-1. PubMed ID: 9235302
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of emerging new technologies.
    Garg SK
    Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
    [No Abstract]   [Full Text] [Related]  

  • 6. [New concepts in blood glucose determination in insulin therapy].
    Kellerer M
    Krankenpfl J; 2005; 43(4-6):149. PubMed ID: 16171092
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
    Becker RH; Frick AD; Nosek L; Heinemann L; Rave K
    Diabetes Care; 2007 Oct; 30(10):2506-7. PubMed ID: 17675541
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefits of combination therapy of insulin and oral hypoglycemic agents.
    Garber AJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1781-2. PubMed ID: 12912710
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin.
    Hayashi T; Murayama H; Shinfuku Y; Taniguchi T; Tsumiyama I; Oyama N
    Expert Opin Pharmacother; 2020 Jan; 21(1):121-130. PubMed ID: 31689132
    [No Abstract]   [Full Text] [Related]  

  • 10. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 11. Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.
    Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
    J Diabetes Sci Technol; 2013 May; 7(3):800-1. PubMed ID: 23759415
    [No Abstract]   [Full Text] [Related]  

  • 12. Should the target A1C level be less than 7 percent? No: The case for modest glycemic control in patients with type 2 diabetes.
    Barry HC
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316991
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes.
    Ann Intern Med; 2008 Oct; 149(8):I-46. PubMed ID: 18936498
    [No Abstract]   [Full Text] [Related]  

  • 14. Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key.
    Cochran EK; Valentine V; Samaan KH; Corey IB; Jackson JA
    Diabetes Educ; 2014; 40(2):153-65. PubMed ID: 24159006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes: education more effective than drugs? Those who know more, live longer].
    Meissner T
    MMW Fortschr Med; 2003 May; 145(20):14. PubMed ID: 12822224
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired absorption of insulin aspart from lipohypertrophic injection sites.
    Johansson UB; Amsberg S; Hannerz L; Wredling R; Adamson U; Arnqvist HJ; Lins PE
    Diabetes Care; 2005 Aug; 28(8):2025-7. PubMed ID: 16043749
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
    Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
    J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2005 Jul; 28(7):1834-5. PubMed ID: 15983352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.